Silencing RUVBL2 in HCC cells reduced cell growth, increased apoptosis and induced cell senescence and migration; therefore, it is associated with poor prognosis and chemoresistance [16, 21–23]. This evidence concerns the gene RUVBL2 and hepatocellular carcinoma.